Does the media refer more to TEM or DGX?

In the previous week, Tempus AI had 12 more articles in the media than Quest Diagnostics. MarketBeat recorded 43 mentions for Tempus AI and 31 mentions for Quest Diagnostics. Quest Diagnostics' average media sentiment score of 1.37 beat Tempus AI's score of 0.48 indicating that Quest Diagnostics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tempus AI 22 Very Positive mention(s) 4 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Quest Diagnostics 27 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, LH or TEM?

Labcorp has higher revenue and earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Labcorp $13.95B 1.95 $876.50M $12.09 27.79 Tempus AI $1.43B 9.16 -$245.03M -$1.44 N/A

Is LH or TEM more profitable?

Labcorp has a net margin of 6.99% compared to Tempus AI's net margin of -17.77%. Labcorp's return on equity of 16.74% beat Tempus AI's return on equity. Company Net Margins Return on Equity Return on Assets Labcorp 6.99% 16.74% 7.81% Tempus AI -17.77% -50.28% -10.33%

Does the media prefer LH or TEM?

In the previous week, Tempus AI had 35 more articles in the media than Labcorp. MarketBeat recorded 43 mentions for Tempus AI and 8 mentions for Labcorp. Labcorp's average media sentiment score of 0.66 beat Tempus AI's score of 0.48 indicating that Labcorp is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Labcorp 4 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tempus AI 22 Very Positive mention(s) 4 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation & earnings, TEM or GH?

Tempus AI has higher revenue and earnings than Guardant Health. Tempus AI is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Tempus AI $1.43B 9.16 -$245.03M -$1.44 N/A Guardant Health $982.02M 23.33 -$416.28M -$3.49 N/A

Does the media refer more to TEM or GH?

In the previous week, Tempus AI had 30 more articles in the media than Guardant Health. MarketBeat recorded 43 mentions for Tempus AI and 13 mentions for Guardant Health. Guardant Health's average media sentiment score of 1.40 beat Tempus AI's score of 0.48 indicating that Guardant Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tempus AI 22 Very Positive mention(s) 4 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Guardant Health 11 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer TEM or FMS?

In the previous week, Tempus AI had 41 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 43 mentions for Tempus AI and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.27 beat Tempus AI's score of 0.48 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tempus AI 22 Very Positive mention(s) 4 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Fresenius Medical Care AG & Co. KGaA 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer TEM or BTSG?

In the previous week, Tempus AI had 36 more articles in the media than BrightSpring Health Services. MarketBeat recorded 43 mentions for Tempus AI and 7 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.23 beat Tempus AI's score of 0.48 indicating that BrightSpring Health Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tempus AI 22 Very Positive mention(s) 4 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral BrightSpring Health Services 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Tempus AI (TEM) Competitors

$72.69 +6.04 (+9.06%)

As of 08/21/2026 04:00 PM Eastern

Compare

TEM vs. DGX, LH, GH, FMS, and BTSG

Should you buy Tempus AI stock or one of its competitors? Tempus AI's main competitors and comparable companies include Quest Diagnostics (DGX), Labcorp (LH), Guardant Health (GH), Fresenius Medical Care AG & Co. KGaA (FMS), and BrightSpring Health Services (BTSG). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Tempus AI compare to Quest Diagnostics?

Tempus AI (NASDAQ:TEM) and Quest Diagnostics (NYSE:DGX) are both large-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership and profitability.

Tempus AI has a beta of 3.58, suggesting that its share price is 258% more volatile than the broader market. Comparatively, Quest Diagnostics has a beta of 0.56, suggesting that its share price is 44% less volatile than the broader market.

Quest Diagnostics has a net margin of 9.18% compared to Tempus AI's net margin of -17.77%. Quest Diagnostics' return on equity of 16.01% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tempus AI	-17.77%	-50.28%	-10.33%
Quest Diagnostics	9.18%	16.01%	7.27%

24.2% of Tempus AI shares are held by institutional investors. Comparatively, 88.1% of Quest Diagnostics shares are held by institutional investors. 24.3% of Tempus AI shares are held by insiders. Comparatively, 0.9% of Quest Diagnostics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Tempus AI currently has a consensus target price of $65.69, suggesting a potential downside of 9.63%. Quest Diagnostics has a consensus target price of $235.31, suggesting a potential downside of 3.70%. Given Quest Diagnostics' stronger consensus rating and higher probable upside, analysts clearly believe Quest Diagnostics is more favorable than Tempus AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tempus AI	2 Sell rating(s)	6 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.41
Quest Diagnostics	0 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.54

In the previous week, Tempus AI had 12 more articles in the media than Quest Diagnostics. MarketBeat recorded 43 mentions for Tempus AI and 31 mentions for Quest Diagnostics. Quest Diagnostics' average media sentiment score of 1.37 beat Tempus AI's score of 0.48 indicating that Quest Diagnostics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tempus AI	22 Very Positive mention(s)	4 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Quest Diagnostics	27 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Quest Diagnostics has higher revenue and earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than Quest Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tempus AI	$1.43B	9.16	-$245.03M	-$1.44	N/A
Quest Diagnostics	$11.04B	2.44	$992M	$9.42	25.94

Summary

Quest Diagnostics beats Tempus AI on 12 of the 17 factors compared between the two stocks.

How does Tempus AI compare to Labcorp?

Labcorp (NYSE:LH) and Tempus AI (NASDAQ:TEM) are both large-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, media sentiment, analyst recommendations and risk.

Labcorp has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market. Comparatively, Tempus AI has a beta of 3.58, suggesting that its share price is 258% more volatile than the broader market.

Labcorp has higher revenue and earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Labcorp	$13.95B	1.95	$876.50M	$12.09	27.79
Tempus AI	$1.43B	9.16	-$245.03M	-$1.44	N/A

In the previous week, Tempus AI had 35 more articles in the media than Labcorp. MarketBeat recorded 43 mentions for Tempus AI and 8 mentions for Labcorp. Labcorp's average media sentiment score of 0.66 beat Tempus AI's score of 0.48 indicating that Labcorp is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Labcorp	4 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tempus AI	22 Very Positive mention(s)	4 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Labcorp presently has a consensus price target of $330.00, indicating a potential downside of 1.79%. Tempus AI has a consensus price target of $65.69, indicating a potential downside of 9.63%. Given Labcorp's stronger consensus rating and higher probable upside, equities research analysts plainly believe Labcorp is more favorable than Tempus AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Labcorp	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.75
Tempus AI	2 Sell rating(s)	6 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.41

95.9% of Labcorp shares are held by institutional investors. Comparatively, 24.2% of Tempus AI shares are held by institutional investors. 0.8% of Labcorp shares are held by insiders. Comparatively, 24.3% of Tempus AI shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Labcorp has a net margin of 6.99% compared to Tempus AI's net margin of -17.77%. Labcorp's return on equity of 16.74% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Labcorp	6.99%	16.74%	7.81%
Tempus AI	-17.77%	-50.28%	-10.33%

Summary

Labcorp beats Tempus AI on 11 of the 15 factors compared between the two stocks.

How does Tempus AI compare to Guardant Health?

Tempus AI (NASDAQ:TEM) and Guardant Health (NASDAQ:GH) are both large-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk, media sentiment and institutional ownership.

Tempus AI has a net margin of -17.77% compared to Guardant Health's net margin of -38.33%. Guardant Health's return on equity of 0.00% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tempus AI	-17.77%	-50.28%	-10.33%
Guardant Health	-38.33%	N/A	-25.40%

Tempus AI currently has a consensus price target of $65.69, suggesting a potential downside of 9.63%. Guardant Health has a consensus price target of $183.78, suggesting a potential upside of 7.67%. Given Guardant Health's stronger consensus rating and higher probable upside, analysts plainly believe Guardant Health is more favorable than Tempus AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tempus AI	2 Sell rating(s)	6 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.41
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96

In the previous week, Tempus AI had 30 more articles in the media than Guardant Health. MarketBeat recorded 43 mentions for Tempus AI and 13 mentions for Guardant Health. Guardant Health's average media sentiment score of 1.40 beat Tempus AI's score of 0.48 indicating that Guardant Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tempus AI	22 Very Positive mention(s)	4 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Guardant Health	11 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Tempus AI has higher revenue and earnings than Guardant Health. Tempus AI is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tempus AI	$1.43B	9.16	-$245.03M	-$1.44	N/A
Guardant Health	$982.02M	23.33	-$416.28M	-$3.49	N/A

Tempus AI has a beta of 3.58, meaning that its share price is 258% more volatile than the broader market. Comparatively, Guardant Health has a beta of 1.6, meaning that its share price is 60% more volatile than the broader market.

24.2% of Tempus AI shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 24.3% of Tempus AI shares are owned by company insiders. Comparatively, 5.6% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Guardant Health beats Tempus AI on 9 of the 17 factors compared between the two stocks.

How does Tempus AI compare to Fresenius Medical Care AG & Co. KGaA?

Tempus AI (NASDAQ:TEM) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, institutional ownership, valuation, risk, earnings and media sentiment.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tempus AI	$1.43B	9.16	-$245.03M	-$1.44	N/A
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.57	$1.11B	$1.93	12.14

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to Tempus AI's net margin of -17.77%. Fresenius Medical Care AG & Co. KGaA's return on equity of 9.28% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tempus AI	-17.77%	-50.28%	-10.33%
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%

In the previous week, Tempus AI had 41 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 43 mentions for Tempus AI and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.27 beat Tempus AI's score of 0.48 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tempus AI	22 Very Positive mention(s)	4 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

24.2% of Tempus AI shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 24.3% of Tempus AI shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Tempus AI has a beta of 3.58, meaning that its share price is 258% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.77, meaning that its share price is 23% less volatile than the broader market.

Tempus AI presently has a consensus target price of $65.69, indicating a potential downside of 9.63%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $23.57, indicating a potential upside of 0.58%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Tempus AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tempus AI	2 Sell rating(s)	6 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.41
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.55

Summary

Fresenius Medical Care AG & Co. KGaA beats Tempus AI on 9 of the 16 factors compared between the two stocks.

How does Tempus AI compare to BrightSpring Health Services?

Tempus AI (NASDAQ:TEM) and BrightSpring Health Services (NASDAQ:BTSG) are both large-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and valuation.

Tempus AI has a beta of 3.58, indicating that its share price is 258% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.88, indicating that its share price is 88% more volatile than the broader market.

BrightSpring Health Services has a net margin of 2.55% compared to Tempus AI's net margin of -17.77%. BrightSpring Health Services' return on equity of 16.73% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tempus AI	-17.77%	-50.28%	-10.33%
BrightSpring Health Services	2.55%	16.73%	5.24%

In the previous week, Tempus AI had 36 more articles in the media than BrightSpring Health Services. MarketBeat recorded 43 mentions for Tempus AI and 7 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.23 beat Tempus AI's score of 0.48 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tempus AI	22 Very Positive mention(s)	4 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
BrightSpring Health Services	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

BrightSpring Health Services has higher revenue and earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tempus AI	$1.43B	9.16	-$245.03M	-$1.44	N/A
BrightSpring Health Services	$12.91B	0.90	$190.67M	$1.66	35.46

24.2% of Tempus AI shares are owned by institutional investors. 24.3% of Tempus AI shares are owned by insiders. Comparatively, 2.8% of BrightSpring Health Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Tempus AI currently has a consensus price target of $65.69, indicating a potential downside of 9.63%. BrightSpring Health Services has a consensus price target of $70.71, indicating a potential upside of 20.11%. Given BrightSpring Health Services' stronger consensus rating and higher probable upside, analysts clearly believe BrightSpring Health Services is more favorable than Tempus AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tempus AI	2 Sell rating(s)	6 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.41
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	3.10

Summary

BrightSpring Health Services beats Tempus AI on 12 of the 17 factors compared between the two stocks.

Get Tempus AI News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TEM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TEM vs. The Competition

Export

Metric	Tempus AI	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$12.03B	$9.74B	$7.26B	$12.77B
Dividend Yield	N/A	2.55%	2.54%	11.08%
P/E Ratio	-50.48	34.38	273.18	24.24
Price / Sales	9.16	5.02	689.05	129.21
Price / Cash	N/A	124.12	76.89	53.23
Price / Book	29.43	4.05	13.45	6.38
Net Income	-$245.03M	$311.06M	$3.47B	$348.73M
7 Day Performance	39.52%	0.83%	2.08%	0.08%
1 Month Performance	54.79%	1.29%	6.10%	2.91%
1 Year Performance	-9.72%	15.68%	24.99%	17.19%

Tempus AI Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TEM Tempus AI	1.5782 of 5 stars	$72.69 +9.1%	$65.69 -9.6%	-5.2%	$12.03B	$1.43B	N/A	3,800	Trending News Analyst Forecast Insider Trade Options Volume High Trading Volume
DGX Quest Diagnostics	4.2578 of 5 stars	$235.73 -0.1%	$235.31 -0.2%	+33.1%	$26.02B	$11.04B	25.02	57,000	News Coverage Positive News
LH Labcorp	4.0121 of 5 stars	$320.60 -0.6%	$330.00 +2.9%	+21.5%	$26.00B	$14.35B	26.52	71,000	Insider Trade
GH Guardant Health	2.6211 of 5 stars	$157.87 -1.0%	$183.78 +16.4%	+178.5%	$21.19B	$982.02M	N/A	2,506	Positive News
FMS Fresenius Medical Care AG & Co. KGaA	3.1768 of 5 stars	$23.74 +0.4%	$23.57 -0.7%	-7.1%	$12.75B	$19.43B	12.30	1,488	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TEM) was last updated on 8/22/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Tempus AI (TEM) Competitors

TEM vs. DGX, LH, GH, FMS, and BTSG

How does Tempus AI compare to Quest Diagnostics?

Summary

How does Tempus AI compare to Labcorp?

Summary

How does Tempus AI compare to Guardant Health?

Summary

How does Tempus AI compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Tempus AI compare to BrightSpring Health Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TEM vs. The Competition

Tempus AI Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Tempus AI (TEM) Competitors

TEM vs. DGX, LH, GH, FMS, and BTSG

How does Tempus AI compare to Quest Diagnostics?

Which has more risk and volatility, TEM or DGX?

Is TEM or DGX more profitable?

Do institutionals & insiders have more ownership in TEM or DGX?

Do analysts rate TEM or DGX?

Does the media refer more to TEM or DGX?

Which has better earnings & valuation, TEM or DGX?

Summary

How does Tempus AI compare to Labcorp?

Which has more risk and volatility, LH or TEM?

Which has preferable earnings and valuation, LH or TEM?

Does the media prefer LH or TEM?

Do analysts prefer LH or TEM?

Do institutionals and insiders believe in LH or TEM?

Is LH or TEM more profitable?

Summary

How does Tempus AI compare to Guardant Health?

Is TEM or GH more profitable?

Do analysts prefer TEM or GH?

Does the media refer more to TEM or GH?

Which has preferable valuation & earnings, TEM or GH?

Which has more risk & volatility, TEM or GH?

Do insiders & institutionals have more ownership in TEM or GH?

Summary

How does Tempus AI compare to Fresenius Medical Care AG & Co. KGaA?

Which has better valuation and earnings, TEM or FMS?

Is TEM or FMS more profitable?

Does the media prefer TEM or FMS?

Do insiders and institutionals believe in TEM or FMS?

Which has more risk & volatility, TEM or FMS?

Do analysts prefer TEM or FMS?

Summary

How does Tempus AI compare to BrightSpring Health Services?

Which has more volatility and risk, TEM or BTSG?

Is TEM or BTSG more profitable?

Does the media prefer TEM or BTSG?

Which has stronger earnings & valuation, TEM or BTSG?

Do institutionals & insiders believe in TEM or BTSG?

Do analysts recommend TEM or BTSG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TEM vs. The Competition

Tempus AI Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools